NDC 52565-113

FORTAZ

Ceftazidime Sodium

FORTAZ is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teligent Pharma, Inc.. The primary component is Ceftazidime.

Product ID52565-113_da2c70ba-ae63-494a-88d7-082b32ab4f7c
NDC52565-113
Product TypeHuman Prescription Drug
Proprietary NameFORTAZ
Generic NameCeftazidime Sodium
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2013-04-15
Marketing CategoryNDA / NDA
Application NumberNDA050634
Labeler NameTeligent Pharma, Inc.
Substance NameCEFTAZIDIME
Active Ingredient Strength40 mg/mL
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 52565-113-12

24 CONTAINER in 1 CARTON (52565-113-12) > 50 mL in 1 CONTAINER
Marketing Start Date2016-10-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52565-113-12 [52565011312]

FORTAZ INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA050634
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-10-19
Marketing End Date2019-09-12

Drug Details

Active Ingredients

IngredientStrength
CEFTAZIDIME40 mg/mL

OpenFDA Data

SPL SET ID:78982c98-7866-49f1-989f-a289c4242358
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1659281
  • 1659283
  • 1659285
  • 1659287
  • 1659289
  • 1659278
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "FORTAZ" or generic name "Ceftazidime Sodium"

    NDCBrand NameGeneric Name
    52565-105FORTAZceftazidime
    52565-106FORTAZceftazidime
    52565-107FORTAZceftazidime
    52565-109FORTAZceftazidime
    52565-110FORTAZceftazidime
    52565-111FORTAZceftazidime
    52565-112FORTAZceftazidime sodium
    52565-113FORTAZceftazidime sodium

    Trademark Results [FORTAZ]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    FORTAZ
    FORTAZ
    73376990 1286762 Live/Registered
    Glaxo Group Limited
    1982-07-28

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.